Alira Health’s Global Market Access (GMA) service provides tailored, end-to-end support for healthcare companies seeking successful market entry and sustainable commercial growth across Europe (EU), the United Kingdom, and the United States. Leveraging deep expertise across regulatory, clinical, commercial, and payer landscapes, GMA guides clients through the complexities of market access, reimbursement, and health technology assessment (HTA). The service helps companies develop evidence-based value propositions and pricing strategies aligned with payer expectations and health system requirements. Alira Health works closely with stakeholders, including regulatory bodies, payers, clinicians, and patient groups, to optimise patient access and maximise commercial opportunities for medical products, devices, in vitro diagnostics, and innovative therapies. Their approach spans the full product lifecycle, from early development planning and clinical trial design to dossier preparation, pricing negotiations, and post-market surveillance. GMA also supports digital health solutions, rare disease therapies, and combination products, ensuring comprehensive market readiness. With a focus on integrating global insights and local market intelligence, Alira Health empowers clients to navigate reimbursement challenges, secure optimal pricing and reimbursement, and ultimately achieve timely patient access and market success.